Exact Sciences (EXAS) News Today $51.55 +4.39 (+9.31%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$51.68 +0.13 (+0.24%) As of 05/2/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Analysts Offer Insights on Healthcare Companies: CVS Health (CVS), Exact Sciences (EXAS) and Arvinas Holding Company (ARVN)May 4 at 5:31 AM | theglobeandmail.comExact Sciences Co. (NASDAQ:EXAS) Stock Position Reduced by PDT Partners LLCPDT Partners LLC trimmed its position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 77.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,226 shares of the medical research company's stock after selling 34,584 sharMay 4 at 5:16 AM | marketbeat.comStifel Financial Corp Sells 12,202 Shares of Exact Sciences Co. (NASDAQ:EXAS)Stifel Financial Corp reduced its position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 15.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 68,759 shares of the medical research company'sMay 4 at 4:02 AM | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Shares Sold by NewEdge Advisors LLCNewEdge Advisors LLC lessened its holdings in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 66.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,989 shares of the medical research company's stock afterMay 4 at 3:43 AM | marketbeat.comExact Sciences (NASDAQ:EXAS) Shares Gap Up After Earnings BeatMay 4 at 1:23 AM | americanbankingnews.comExact Sciences Q1 Earnings: Decent Quarter, But Growth Story Not CompellingMay 2 at 1:09 PM | seekingalpha.comCancer Diagnostic Firm Exact Sciences' CEO Says Strong Q1 Paves Way For 'Transformative' 2025, Lifts Annual GuidanceMay 2 at 9:18 AM | benzinga.comExact sciences raises 2025 revenue guidance to $3.12B driven by Cologuard Plus launchMay 2 at 8:33 AM | msn.comExact Sciences to Participate in May Investor ConferenceMay 2 at 6:00 AM | businesswire.comExact Sciences Corporation (EXAS) Q1 2025 Earnings Call TranscriptMay 1 at 9:02 PM | seekingalpha.comExact Sciences Corporation 2025 Q1 - Results - Earnings Call PresentationMay 1 at 8:47 PM | seekingalpha.comExact Sciences climbs on full year guidance raise, revenue beatMay 1 at 7:56 PM | msn.comExact Sciences (NASDAQ:EXAS) Posts Better-Than-Expected Sales In Q1, Stock SoarsMay 1 at 7:56 PM | finance.yahoo.comExact Sciences Announces First-Quarter 2025 ResultsMay 1 at 4:17 PM | businesswire.comSoros Fund Management LLC Buys 118,348 Shares of Exact Sciences Co. (NASDAQ:EXAS)Soros Fund Management LLC boosted its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 31.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 496,938 shares of the medical research company's stock afMay 1 at 8:22 AM | marketbeat.comExact Sciences (EXAS) Reports Q1: Everything You Need To Know Ahead Of EarningsApril 30, 2025 | finance.yahoo.comExact Sciences to Highlight Cologuard® Test Adherence and Predicted Preference Data at Digestive Disease Week (DDW) 2025April 29, 2025 | finance.yahoo.comSusquehanna Fundamental Investments LLC Takes $12.66 Million Position in Exact Sciences Co. (NASDAQ:EXAS)Susquehanna Fundamental Investments LLC acquired a new position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 225,360 shares of the medical research company's stock, valued at approximately $12April 29, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Buys Shares of 378,200 Exact Sciences Co. (NASDAQ:EXAS)Adage Capital Partners GP L.L.C. purchased a new position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 378,200 shares of the medical rApril 29, 2025 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Shares Bought by Hsbc Holdings PLCHsbc Holdings PLC lifted its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 24.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 342,102 shares of the medical research compApril 29, 2025 | marketbeat.comTower Research Capital LLC TRC Purchases 11,745 Shares of Exact Sciences Co. (NASDAQ:EXAS)Tower Research Capital LLC TRC grew its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 1,063.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 12,849 shares of theApril 29, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Grows Stake in Exact Sciences Co. (NASDAQ:EXAS)Price T Rowe Associates Inc. MD grew its stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 74.7% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 5,760,241 shares of the medical research company's stock afterApril 28, 2025 | marketbeat.comNebula Research & Development LLC Invests $3.28 Million in Exact Sciences Co. (NASDAQ:EXAS)Nebula Research & Development LLC acquired a new stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 58,439 shares of the medical research coApril 27, 2025 | marketbeat.comThis Exact Sciences Insider Increased Their Holding In The Last YearApril 26, 2025 | finance.yahoo.com13,520 Shares in Exact Sciences Co. (NASDAQ:EXAS) Acquired by Syon Capital LLCSyon Capital LLC purchased a new position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 13,520 shares of the medical research company's stock, valuApril 26, 2025 | marketbeat.comT. Rowe Price Investment Management Inc. Has $239.92 Million Position in Exact Sciences Co. (NASDAQ:EXAS)T. Rowe Price Investment Management Inc. raised its position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 25.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,269,823 shApril 26, 2025 | marketbeat.comFirst Trust Advisors LP Decreases Stock Position in Exact Sciences Co. (NASDAQ:EXAS)First Trust Advisors LP trimmed its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 3.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 802,767 shares of the medical research company's stApril 26, 2025 | marketbeat.com101,173 Shares in Exact Sciences Co. (NASDAQ:EXAS) Acquired by Marshall Wace LLPMarshall Wace LLP bought a new stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 101,173 shares of the medical research company's stock, valued at approxApril 26, 2025 | marketbeat.comExact Sciences (EXAS) Projected to Post Earnings on ThursdayExact Sciences (NASDAQ:EXAS) will be releasing its Q1 2025 earnings after the market closes on Thursday, May 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-1-exact-sciences-co-stock/)April 26, 2025 | marketbeat.comLeerink Partnrs Predicts Weaker Earnings for Exact SciencesExact Sciences Co. (NASDAQ:EXAS - Free Report) - Leerink Partnrs decreased their Q1 2025 earnings per share estimates for shares of Exact Sciences in a report released on Monday, April 21st. Leerink Partnrs analyst P. Souda now forecasts that the medical research company will earn ($0.14) per shaApril 25, 2025 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Position Increased by BI Asset Management Fondsmaeglerselskab A SBI Asset Management Fondsmaeglerselskab A S raised its position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 662.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,290 shares of tApril 25, 2025 | marketbeat.com2 Reasons to Like EXAS (and 1 Not So Much)April 24, 2025 | finance.yahoo.comExact Sciences (EXAS): Among Billionaire George Soros’ Small-Cap Stocks with Huge Upside PotentialApril 24, 2025 | finance.yahoo.comLeerink Partnrs Forecasts Higher Earnings for Exact SciencesExact Sciences Co. (NASDAQ:EXAS - Free Report) - Analysts at Leerink Partnrs raised their Q3 2025 EPS estimates for shares of Exact Sciences in a research note issued to investors on Monday, April 21st. Leerink Partnrs analyst P. Souda now expects that the medical research company will earn $0.17April 24, 2025 | marketbeat.comQ3 EPS Estimates for Exact Sciences Increased by AnalystApril 24, 2025 | americanbankingnews.comLeerink Partnrs Expects Weaker Earnings for Exact SciencesApril 24, 2025 | americanbankingnews.comExact Sciences (NASDAQ:EXAS) Trading 5.7% Higher - Here's What HappenedExact Sciences (NASDAQ:EXAS) Trading Up 5.7% - What's Next?April 23, 2025 | marketbeat.comExact Sciences launches the Oncodetect MRD testApril 23, 2025 | markets.businessinsider.comRock Springs Capital Management LP Has $25.29 Million Stock Position in Exact Sciences Co. (NASDAQ:EXAS)Rock Springs Capital Management LP lowered its position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 60.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 450,000 shares of the medical research company's stoApril 23, 2025 | marketbeat.comExact Sciences Launches New Test To Monitor Cancer Recurrence: Retail’s OptimisticApril 22, 2025 | msn.comExact Sciences Launches the Oncodetectâ„¢ Molecular Residual Disease TestApril 22, 2025 | businesswire.comExact Sciences Co. (NASDAQ:EXAS) Shares Bought by Thematics Asset ManagementThematics Asset Management lifted its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 26.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 87,572 shares of the medicalApril 22, 2025 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Shares Bought by Capital World InvestorsCapital World Investors boosted its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 10.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 17,537,617 shares of the medicaApril 22, 2025 | marketbeat.comInvesco Ltd. Raises Position in Exact Sciences Co. (NASDAQ:EXAS)Invesco Ltd. lifted its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 57.2% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 379,683 shares of the medical research company's stock after purchasing an additional 138,089April 21, 2025 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Holdings Cut by Blue Water Life Science Advisors LPBlue Water Life Science Advisors LP decreased its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 69.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 78,843 shares of the medical research compaApril 20, 2025 | marketbeat.comAltium Capital Management LLC Acquires Shares of 100,000 Exact Sciences Co. (NASDAQ:EXAS)Altium Capital Management LLC bought a new position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 100,000 shares of the medical research company's stock, valued at approximApril 20, 2025 | marketbeat.comXTX Topco Ltd Reduces Position in Exact Sciences Co. (NASDAQ:EXAS)XTX Topco Ltd trimmed its position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 55.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,217 shares of the medical research company's stock afterApril 20, 2025 | marketbeat.comCerity Partners LLC Has $1.54 Million Stake in Exact Sciences Co. (NASDAQ:EXAS)Cerity Partners LLC grew its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 65.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 27,090 shares of the medical research company's stock after purchasingApril 20, 2025 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Given Consensus Rating of "Moderate Buy" by AnalystsExact Sciences Co. (NASDAQ:EXAS - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the twenty-two research firms that are presently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold rating, nineteen have given a buy rating aApril 20, 2025 | marketbeat.comChamplain Investment Partners LLC Reduces Holdings in Exact Sciences Co. (NASDAQ:EXAS)Champlain Investment Partners LLC reduced its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 2.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,437,305 shares of the medical research company's stoApril 19, 2025 | marketbeat.com Get Exact Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EXAS and its competitors with MarketBeat's FREE daily newsletter. Email Address EXAS Media Mentions By Week EXAS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EXAS News Sentiment▼1.000.65▲Average Medical News Sentiment EXAS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EXAS Articles This Week▼2511▲EXAS Articles Average Week Get Exact Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EXAS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alnylam Pharmaceuticals News Biogen News United Therapeutics News BioMarin Pharmaceutical News Incyte News Exelixis News Neurocrine Biosciences News Repligen News Halozyme Therapeutics News Madrigal Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EXAS) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exact Sciences Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exact Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EXAS Stock Free EXAS Stock Alerts